Meet the 2026 Conference Fund Managers

This year’s fund managers bring expertise across resources, technology and global markets with perspectives spanning the US, Asia and beyond.

Meet the 2026 Conference Fund Managers

October 12, 2026
This year’s fund managers bring expertise across resources, technology and global markets with perspectives spanning the US, Asia and beyond.
Read Transcript

Following a global search, the Conference Fund Manager Selection Working Group is pleased to announce the 2026 Conference Fund Managers, a group of experienced who will present their highest-conviction investment ideas in support of groundbreaking medical research.

‍

HM1 invests 35% of its portfolio in the investment ideas presented by the fund managers at the annual Sohn Hearts & Minds Conference, holding these picks for the following twelve months.

‍

Meet the 2026 Conference Fund Managers below and discover more about their investment expertise.

‍

JEREMY BOND

Founder and Chief Investment Officer

Terra Capital (AUS)

‍

Jeremy founded Terra Capital in 2010, launching the long-only Terra Capital Global Natural Resources Fund. The fund has returned over 18% pa. over 16 years, resulting in Terra Capital becoming Australia’s longest running open ended global resources fund.

‍

Jeremy formally worked at RAB Capital’s Special Situations Fund, a US $2.5B long/short strategy focused on mining and energy. The fund was rated the “Best Energy and Natural Resource Fund” by Hedge Fund Review and ranked No.1 in Barron’s Hedge Fund 50 Global rankings in 2007, during Jeremy’s tenure. Prior to RAB, Jeremy worked at Western Australian corporate advisory firm Azure Capital.

‍

‍

‍

RAVI CHOPRA

Founder and Chief Investment Officer

Azora Capital (USA)

‍

Ravi is the Founder and Chief Investment Officer of Azora Capital – an investment firm launched in 2017, focused on the Financial Services sector, employing a fundamental modest-net strategy. Ravi and his team are passionate about financials and have dedicated their careers to researching the space.

‍

Prior to forming Azora, Ravi served as Sector Head of U.S. Financial Services investing at Samlyn Capital, where he was a day-one partner following a lift-out from Sigma Capital. Earlier in his career, Ravi was a Financial Services Analyst at Sigma and an Investment Banking Analyst in Goldman Sachs' Financial Institutions Group. Ravi graduated Phi Beta Kappa and magna cum laude with an A.B. in Economics from Dartmouth College.

‍

ROSS CAMERON

Portfolio Manager

Northcape Capital (AUS)

‍

Ross joined Northcape in 2009 and co-manages Northcape's $8 billion Global Emerging Markets fund, which has outperformed the MSCI EM index by an average 4.4% per annum since inception 18 years ago.

‍

Before joining Northcape, Ross worked at Capital Partners (now CP2) covering a broad range of sectors including financials, industrials and infrastructure. Ross worked in Tokyo for seven years and is fluent in Japanese.

‍

‍

‍

ANDREW CURTAYNE

Portfolio Manager

Milford Asset Management (NZ)

Andrew joined Milford Asset Management’s Global Equities division in 2023.  He is the Portfolio Manager of Milford’s wholesale Global Technology Fund, which focuses on the Information Technology and Communications Services sectors.  As part of this role, he leads Milford’s research on the AI ecosystem.

‍

Prior to joining Milford, Andrew spent three years as a Portfolio Manager at NZ Funds and five years at event-driven hedge fund Melqart Asset Management in London.  Andrew began his career advising on Mergers and Acquisitions at Goldman Sachs in both Auckland and London. Andrew has a Bachelor of Commerce from the University of Auckland with First Class Honours, majoring in Finance and Economics.

‍

‍

SAMANTHA D'AMORE

Founder and Chief Investment Officer

Cymer Capital (USA)

‍

Sam D'Amore is the founder and Chief Investment Officer of Cymer Capital, a concentrated international long-only equity fund investing in mid- to large-cap companies outside the U.S. that solve complex problems.

‍

Before founding Cymer in 2025, Sam was a Portfolio Manager at Trillium Asset Management, co-managing two diversified sustainable core portfolios. Prior to that, she spent 12 years at Jennison Associates as a Managing Director, covering global equities across multiple strategies. She began her career as a sell-side analyst at Credit Suisse and was later an investment analyst at Sound Energy Capital Management, a long-short energy hedge fund.

‍

Sam holds a B.A. in Physics from Harvard University. She serves on the investment committees of Manomet Conservation Sciences and the Unitarian Universalist Common Endowment Fund, and on the board of the Progress for Informatics & Energy Foundation. Originally from Wales, Sam lives outside Boston with her family.

‍

‍

ROBERT MULLIN

Founder & Chief Investment Officer

Marathon Resource Advisors (USA)

‍

Robert Mullin is the Founder & Chief Investment Officer of Marathon Resource Advisors and has been investing in the energy and natural resource sector since 1994. Over the last three plus decades, he has been a portfolio manager at the Franklin/Templeton Group, The Cypress Funds and Tocqueville Asset Management, as well as running his own firms focused on the sector.

‍

Mr. Mullin received his B.A. in Economics from the University of Colorado at Boulder in 1991. He was born and raised in Northern California, lives in San Francisco with his wife and three children and enjoys cooking, keeping up with his relentlessly athletic kids and attending the French Open whenever possible.

‍

In 2022, Mr. Mulin established the Marathon Statera Project, which allocates a portion of fund management and performance fees to causes focused on global conservation and food security, as well as supporting Bay Area female immigrant food businesses and local youth development.

‍

‍

JOHN PINKEL

Partner & Portfolio Manager

Indus Capital (USA)

‍

John D. Pinkel is a Partner of Indus Capital, based in San Francisco, and the Portfolio Manager of the Indus Select Strategy since its inception in 2009. Mr. Pinkel joined Indus Capital in March 2003 and soon after spearheaded many of the firm’s largest long-term investments in China and Taiwan. He joined Indus from Citigroup, where he was Managing Director and Head of Equities for Taiwan. Prior to that, he spent eight years as a securities analyst in Hong Kong, China and South Korea.

In total, he has lived and worked in Asia for over 35 years.

‍

Mr. Pinkel, a CFA charterholder, graduated from the University of California, Santa Barbara, with a BS in Applied Mathematics. He is fluent in Mandarin Chinese.

‍

‍

VIHARI ROSS

Portfolio Manager

Antipodes Partners (AUS)

‍

Vihari Ross is a portfolio manager at Antipodes Partners, working across global equities strategies for the A$21 billion firm. She has more than 20 years’ experience in global markets. Before joining Antipodes, she spent over 15 years at Magellan Financial Group, where she was Head of Research and led a 30-person global research team. During her time there, she designed and managed the Magellan Core Global strategy. Earlier at Magellan, she covered financials and consumer sectors and served as Sector Head of Franchises (Consumer).

‍

Vihari began her career at Commonwealth Investment Management in strategy and research, later joining Ausbil Dexia from 2003 to 2007 as an analyst covering financials and consumer sectors, with additional responsibility for quantitative analysis. She holds a Bachelor of Commerce (Actuarial Studies and Finance) and a Master of Commerce (Finance) from UNSW and is an Associate of the Institute of Actuaries.

‍

‍

JOHN WYLIE

Senior Analyst

EFM Asset Management (HK)

John Wylie has over 18 years of experience across portfolio management, equity research, and investment banking with deep expertise in financial institutions, healthcare, and disruptive technologies.

‍

John partnered with EFM’s Chief Investment Officer in 2023 to accelerate the growth of the firm’s successful NexGen public and private equity strategies.

Prior to EFM, John spent eight years at Magellan Asset Management covering global equities in addition to Healthcare Sector Head and Global Fund Portfolio Manager responsibilities. John’s early career as an M&A banker at Citigroup focused on strategic coverage of financial institutions and financial sponsors. John holds a Doctor of Philosophy (Finance) and a Bachelor of Commerce (First Class Honours), both from the University of Sydney.

Following a global search, the Conference Fund Manager Selection Working Group is pleased to announce the 2026 Conference Fund Managers, a group of experienced who will present their highest-conviction investment ideas in support of groundbreaking medical research.

‍

HM1 invests 35% of its portfolio in the investment ideas presented by the fund managers at the annual Sohn Hearts & Minds Conference, holding these picks for the following twelve months.

‍

Meet the 2026 Conference Fund Managers below and discover more about their investment expertise.

‍

JEREMY BOND

Founder and Chief Investment Officer

Terra Capital (AUS)

‍

Jeremy founded Terra Capital in 2010, launching the long-only Terra Capital Global Natural Resources Fund. The fund has returned over 18% pa. over 16 years, resulting in Terra Capital becoming Australia’s longest running open ended global resources fund.

‍

Jeremy formally worked at RAB Capital’s Special Situations Fund, a US $2.5B long/short strategy focused on mining and energy. The fund was rated the “Best Energy and Natural Resource Fund” by Hedge Fund Review and ranked No.1 in Barron’s Hedge Fund 50 Global rankings in 2007, during Jeremy’s tenure. Prior to RAB, Jeremy worked at Western Australian corporate advisory firm Azure Capital.

‍

‍

‍

RAVI CHOPRA

Founder and Chief Investment Officer

Azora Capital (USA)

‍

Ravi is the Founder and Chief Investment Officer of Azora Capital – an investment firm launched in 2017, focused on the Financial Services sector, employing a fundamental modest-net strategy. Ravi and his team are passionate about financials and have dedicated their careers to researching the space.

‍

Prior to forming Azora, Ravi served as Sector Head of U.S. Financial Services investing at Samlyn Capital, where he was a day-one partner following a lift-out from Sigma Capital. Earlier in his career, Ravi was a Financial Services Analyst at Sigma and an Investment Banking Analyst in Goldman Sachs' Financial Institutions Group. Ravi graduated Phi Beta Kappa and magna cum laude with an A.B. in Economics from Dartmouth College.

‍

ROSS CAMERON

Portfolio Manager

Northcape Capital (AUS)

‍

Ross joined Northcape in 2009 and co-manages Northcape's $8 billion Global Emerging Markets fund, which has outperformed the MSCI EM index by an average 4.4% per annum since inception 18 years ago.

‍

Before joining Northcape, Ross worked at Capital Partners (now CP2) covering a broad range of sectors including financials, industrials and infrastructure. Ross worked in Tokyo for seven years and is fluent in Japanese.

‍

‍

‍

ANDREW CURTAYNE

Portfolio Manager

Milford Asset Management (NZ)

Andrew joined Milford Asset Management’s Global Equities division in 2023.  He is the Portfolio Manager of Milford’s wholesale Global Technology Fund, which focuses on the Information Technology and Communications Services sectors.  As part of this role, he leads Milford’s research on the AI ecosystem.

‍

Prior to joining Milford, Andrew spent three years as a Portfolio Manager at NZ Funds and five years at event-driven hedge fund Melqart Asset Management in London.  Andrew began his career advising on Mergers and Acquisitions at Goldman Sachs in both Auckland and London. Andrew has a Bachelor of Commerce from the University of Auckland with First Class Honours, majoring in Finance and Economics.

‍

‍

SAMANTHA D'AMORE

Founder and Chief Investment Officer

Cymer Capital (USA)

‍

Sam D'Amore is the founder and Chief Investment Officer of Cymer Capital, a concentrated international long-only equity fund investing in mid- to large-cap companies outside the U.S. that solve complex problems.

‍

Before founding Cymer in 2025, Sam was a Portfolio Manager at Trillium Asset Management, co-managing two diversified sustainable core portfolios. Prior to that, she spent 12 years at Jennison Associates as a Managing Director, covering global equities across multiple strategies. She began her career as a sell-side analyst at Credit Suisse and was later an investment analyst at Sound Energy Capital Management, a long-short energy hedge fund.

‍

Sam holds a B.A. in Physics from Harvard University. She serves on the investment committees of Manomet Conservation Sciences and the Unitarian Universalist Common Endowment Fund, and on the board of the Progress for Informatics & Energy Foundation. Originally from Wales, Sam lives outside Boston with her family.

‍

‍

ROBERT MULLIN

Founder & Chief Investment Officer

Marathon Resource Advisors (USA)

‍

Robert Mullin is the Founder & Chief Investment Officer of Marathon Resource Advisors and has been investing in the energy and natural resource sector since 1994. Over the last three plus decades, he has been a portfolio manager at the Franklin/Templeton Group, The Cypress Funds and Tocqueville Asset Management, as well as running his own firms focused on the sector.

‍

Mr. Mullin received his B.A. in Economics from the University of Colorado at Boulder in 1991. He was born and raised in Northern California, lives in San Francisco with his wife and three children and enjoys cooking, keeping up with his relentlessly athletic kids and attending the French Open whenever possible.

‍

In 2022, Mr. Mulin established the Marathon Statera Project, which allocates a portion of fund management and performance fees to causes focused on global conservation and food security, as well as supporting Bay Area female immigrant food businesses and local youth development.

‍

‍

JOHN PINKEL

Partner & Portfolio Manager

Indus Capital (USA)

‍

John D. Pinkel is a Partner of Indus Capital, based in San Francisco, and the Portfolio Manager of the Indus Select Strategy since its inception in 2009. Mr. Pinkel joined Indus Capital in March 2003 and soon after spearheaded many of the firm’s largest long-term investments in China and Taiwan. He joined Indus from Citigroup, where he was Managing Director and Head of Equities for Taiwan. Prior to that, he spent eight years as a securities analyst in Hong Kong, China and South Korea.

In total, he has lived and worked in Asia for over 35 years.

‍

Mr. Pinkel, a CFA charterholder, graduated from the University of California, Santa Barbara, with a BS in Applied Mathematics. He is fluent in Mandarin Chinese.

‍

‍

VIHARI ROSS

Portfolio Manager

Antipodes Partners (AUS)

‍

Vihari Ross is a portfolio manager at Antipodes Partners, working across global equities strategies for the A$21 billion firm. She has more than 20 years’ experience in global markets. Before joining Antipodes, she spent over 15 years at Magellan Financial Group, where she was Head of Research and led a 30-person global research team. During her time there, she designed and managed the Magellan Core Global strategy. Earlier at Magellan, she covered financials and consumer sectors and served as Sector Head of Franchises (Consumer).

‍

Vihari began her career at Commonwealth Investment Management in strategy and research, later joining Ausbil Dexia from 2003 to 2007 as an analyst covering financials and consumer sectors, with additional responsibility for quantitative analysis. She holds a Bachelor of Commerce (Actuarial Studies and Finance) and a Master of Commerce (Finance) from UNSW and is an Associate of the Institute of Actuaries.

‍

‍

JOHN WYLIE

Senior Analyst

EFM Asset Management (HK)

John Wylie has over 18 years of experience across portfolio management, equity research, and investment banking with deep expertise in financial institutions, healthcare, and disruptive technologies.

‍

John partnered with EFM’s Chief Investment Officer in 2023 to accelerate the growth of the firm’s successful NexGen public and private equity strategies.

Prior to EFM, John spent eight years at Magellan Asset Management covering global equities in addition to Healthcare Sector Head and Global Fund Portfolio Manager responsibilities. John’s early career as an M&A banker at Citigroup focused on strategic coverage of financial institutions and financial sponsors. John holds a Doctor of Philosophy (Finance) and a Bachelor of Commerce (First Class Honours), both from the University of Sydney.

Disclaimer: This material has been prepared by Hearts & Minds, published on October 12, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.